Concepedia

Bob Argiropoulos

BA

34

Publications

2.7K

Citations

25

H-Index

2001

Active since

Affiliations

University of Calgary(Current)

BC Cancer Agency

Alberta Children's Hospital

University of British Columbia

Medizinische Hochschule Hannover

Bob Argiropoulos is an author at University of Calgary specializing in medicine, genetics, and cell biology.

ORCID

Top concepts

Publications per year

2001–2021

34

Publications

34

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

Daniel T. Starczynowski, Florian Kuchenbauer, Bob Argiropoulos et al. · Nature Medicine · 2009 · 650 citations

, , +10

In-depth characterization of the microRNA transcriptome in a leukemia progression model

Florian Kuchenbauer, Ryan D. Morin, Bob Argiropoulos et al. · Genome Research · 2008 · 174 citations · Full text

Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes

A. C. Lionel, Kristiina Tammimies, Andrea K. Vaags et al. · Human Molecular Genetics · 2013 · 172 citations · Full text

, , +19

DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies

Jianling Ji, Hane Lee, Bob Argiropoulos et al. · European Journal of Human Genetics · 2015 · 150 citations · Full text

, , +8

MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML

Michael Heuser, Bob Argiropoulos, Florian Kuchenbauer et al. · Blood · 2007 · 146 citations · Full text

Rows per page

1–5 of 34